Ignite Creation Date:
2025-12-25 @ 12:01 AM
Ignite Modification Date:
2026-02-25 @ 4:58 PM
Study NCT ID:
NCT00653458
Status:
COMPLETED
Last Update Posted:
2008-04-11
First Post:
2008-04-04
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Bioavailability Study of Ondansetron Orally Disintegrating Tablets Under Fed Conditions
Sponsor:
Par Pharmaceutical, Inc.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
ODO-P2-159
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
Dr.Alfred Elvin/ Diector Biopharmaceutics
Old Organization:
Par Pharmaceutical, Inc.
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | INDUSTRY | View |